1. De Villiers, A. S., Russell, V. A., Carstens, M. E., Aalbers, C., Gagiano, C. A., Chalton, D. O., and Taljaard, J. J. F. 1986. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder. Psychiatry Res. 22:127?140.
2. Schildkraut, J. J. 1978. Current status of the catecholamine hypothesis of affective disorders. In Psychopharmacology: A generation of progress, pp 122?134, Lipton, MA, Dimascio, A., and Killam K. F. (Eds) New York, Raven Press.
3. Carstens, M. E., Engelbrecht, A. H., Russell V. A., Aalbers, C., Gagiano, C. A., Chalton, D. O., and Taljaard, J. J. F. 1986. Alpha2 adrenoceptor levels on platelets of patients with major depressive disorder. Psychiatry Res. 18:321?331.
4. Carstens, M. E., Engelbrecht, A. H., Russell, V. A., Van Zyl, A. M., and Taljaard, J. J. F. 1987. Biological markers in juvenile depression. Psychiatry Res. 23:77?88.
5. Siever, L. J., and Davis, K. L. 1984. Regulations of neurotransmitter systems: implications for the major psychiatric syndromes and their treatment. Psychopharmacol. Bull. 20:500?504.